• 1
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:115164.
  • 2
    Von Boehmer H. Dynamics of suppressor T cells: in vivo veritas. J Exp Med 2003; 198:8459.
  • 3
    Takahashi T, Kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:196980.
  • 4
    Thornton AM, Shevach EM. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:28796.
  • 5
    Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci USA 2004; 101:10398403.
  • 6
    Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4 (+) CD25 (+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194:62944.
  • 7
    Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM. CD4 (+) CD25 (+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002; 196:23746.
  • 8
    De La Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol 2004; 34:24808.
  • 9
    Scheffold A, Huhn J, Hofer T. Regulation of CD4 (+) CD25 (+) regulatory T cell activity: it takes (IL-) two to tango. Eur J Immunol 2005; 35:133641.
  • 10
    Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005; 6:114251.
  • 11
    Ermann J, Szanya V, Ford GS, Paragas V, Fathman CG, Lejon K. CD4 (+) CD25 (+) T cells facilitate the induction of T cell anergy. J Immunol 2001; 167:42715.
  • 12
    Fallarino F, Grohmann U, Hwang KW et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4:120612.
  • 13
    Serra P, Amrani A, Yamanouchi J et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+ CD25+ T cells. Immunity 2003; 19:87789.
  • 14
    Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge. human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004; 172:467680.
  • 15
    Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 2004; 172:277884.
  • 16
    Fehervari Z, Sakaguchi S. Control of Foxp3+ CD25+ CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 2004; 16:176980.
  • 17
    Guiducci C, Valzasina B, Dislich H, Colombo MP. CD40/CD40L interaction regulates CD4+ CD25+ T reg homeostasis through dendritic cell-produced IL-2. Eur J Immunol 2005; 35:55767.
  • 18
    Tang Q, Adams JY, Tooley AJ et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006; 7:8392.
  • 19
    Lewkowich IP, Herman NS, Schleifer KW et al. CD4+ CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005; 202:154961.
  • 20
    Cederbom L, Hall H, Ivars F. CD4+ CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30:153843.
  • 21
    Laich A, Neurauter G, Widner B, Fuchs D. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 2002; 48:57981.
  • 22
    Chai JG, Tsang JY, Lechler R, Simpson E, Dyson J, Scott D. CD4+ CD25+ T cells as immunoregulatory T cells in vitro. Eur J Immunol 2002; 32:236575.
  • 23
    George TC, Bilsborough J, Viney JL, Norment AM. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. Eur J Immunol 2003; 33:50211.
  • 24
    Piccirillo CA, Shevach EM. Cutting edge: control of CD8 (+) T cell activation by CD4 (+) CD25 (+) immunoregulatory cells. J Immunol 2001; 167:113740.
  • 25
    Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12:43140.
  • 26
    Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295302.
  • 27
    Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25 (+) CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:30310.
  • 28
    Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA. Distinct roles of CTLA-4 and TGF-beta in CD4+ CD25+ regulatory T cell function. Eur J Immunol 2004; 34:29963005.
  • 29
    Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1:40513.
  • 30
    Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 [see comments]. Science 1995; 270:9858.
  • 31
    Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3:5417.
  • 32
    Chambers CA, Cado D, Truong T, Allison JP. Thymocyte development is normal in CTLA-4-deficient mice. Proc Natl Acad Sci USA 1997; 94:9296301.
  • 33
    Kataoka H, Takahashi S, Takase K, Yamasaki S, Yokosuka T, Koike T, Saito T. CD25 (+) CD4 (+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4. Int Immunol 2005; 17:4217.
  • 34
    Thornton AM, Donovan EE, Piccirillo CA, Shevach EM. Cutting edge. IL-2 is critically required for the in vitro activation of CD4+ CD25+ T cell suppressor function. J Immunol 2004; 172:651923.
  • 35
    Janssens W, Carlier V, Wu B, VanderElst L, Jacquemin MG, Saint-Remy JM. CD4+ CD25+ T cells lyse antigen-presenting B cells by Fas–Fas ligand interaction in an epitope-specific manner. J Immunol 2003; 171:460412.
  • 36
    Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21:589601.
  • 37
    Nolte-′t Hoen EN, Wagenaar-Hilbers JP, Peters PJ, Gadella BM, Van Eden W, Wauben MH. Uptake of membrane molecules from T cells endows antigen-presenting cells with novel functional properties. Eur J Immunol 2004; 34:311525.
  • 38
    Kumanogoh A, Wang X, Lee I et al. Increased T cell autoreactivity in the absence of CD40–CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 2001; 166:35360.
  • 39
    Lu L, Bonham CA, Chambers FG, Watkins SC, Hoffman RA, Simmons RL, Thomson AW. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol 1996; 157:357786.
  • 40
    Grundstrom S, Cederbom L, Sundstedt A, Scheipers P, Ivars F. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+ CD25+ regulatory T cells in vivo. J Immunol 2003; 170:500817.
  • 41
    Vendetti S, Chai JG, Dyson J, Simpson E, Lombardi G, Lechler R. Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol 2000; 165:117581.
  • 42
    Thornton AM, Piccirillo CA, Shevach EM. Activation requirements for the induction of CD4+ CD25+ T cell suppressor function. Eur J Immunol 2004; 34:36676.
  • 43
    Hwang I, Huang JF, Kishimoto H et al. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells [in process citation]. J Exp Med 2000; 191:113748.
  • 44
    Magistrelli G, Jeannin P, Herbault N, Benoit De Coignac A, Gauchat JF, Bonnefoy JY, Delneste Y. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999; 29:3596602.
  • 45
    Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ. A native soluble form of CTLA-4. Cell Immunol 2000; 201:14453.
  • 46
    Lindsten T, Lee KP, Harris ES et al. Characterization of CTLA-4 structure and expression on human T cells. J Immunol 1993; 151:348999.
  • 47
    Chen W, Jin W, Wahl SM. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4 (+) T cells. J Exp Med 1998; 188:184957.
  • 48
    Thornton AM, Shevach EM. Suppressor effector function of CD4+ CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164:18390.
  • 49
    Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro[see comments]. Science 1994; 264:15879.
  • 50
    Frasca L, Carmichael P, Lechler R, Lombardi G. Anergic T cells effect linked suppression. Eur J Immunol 1997; 27:31917.
  • 51
    Taams LS, Van Rensen AJ, Poelen MC et al. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol 1998; 28:290212.